Preventing lung cancer requires a combination of lifestyle, environmental, and clinical measures aimed at reducing exposure to known risk factors and promoting early detection. Tobacco use remains the single largest contributor to lung cancer, making smoking cessation programs a cornerstone of prevention. These programs include counseling, pharmacologic aids, nicotine replacement therapy, and public awareness campaigns to discourage initiation and support cessation. In addition, minimizing exposure to secondhand smoke, occupational carcinogens such as asbestos or diesel fumes, and environmental pollutants is essential to lower risk. Genetic predisposition and pre-existing lung conditions also influence individual susceptibility, highlighting the need for personalized prevention approaches.
Screening and early detection play a vital role in preventing advanced disease. Low-dose computed tomography (LDCT) screening in high-risk populations allows for identification of early-stage lung cancers that can be treated more effectively, improving survival rates. Public health initiatives, including education about symptom awareness and regular health check-ups, support timely medical evaluation. Lifestyle interventions such as maintaining a balanced diet rich in fruits and vegetables, engaging in regular physical activity, and managing chronic respiratory conditions further contribute to lowering risk. At the policy level, regulatory measures to control air pollution, enforce workplace safety, and reduce tobacco availability are critical. Comprehensive lung cancer prevention strategies integrate individual behavior modification, community health initiatives, and policy enforcement to reduce incidence, promote early diagnosis, and enhance overall population respiratory health
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal